SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-18-018329
Filing Date
2018-03-30
Accepted
2018-03-30 17:26:36
Documents
76
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A tv481831_10qa.htm 10-Q/A 372585
2 EXHIBIT 31.1 tv481831_ex31-1.htm EX-31.1 8227
3 EXHIBIT 31.2 tv481831_ex31-2.htm EX-31.2 8376
4 EXHIBIT 32.1 tv481831_ex32-1.htm EX-32.1 3592
5 EXHIBIT 32.2 tv481831_ex32-2.htm EX-32.2 3561
  Complete submission text file 0001144204-18-018329.txt   5038893

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xtnt-20170630.xml EX-101.INS 1069595
7 XBRL TAXONOMY EXTENSION SCHEMA xtnt-20170630.xsd EX-101.SCH 56948
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtnt-20170630_cal.xml EX-101.CAL 59283
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtnt-20170630_def.xml EX-101.DEF 369460
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtnt-20170630_lab.xml EX-101.LAB 417058
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtnt-20170630_pre.xml EX-101.PRE 411176
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-34951 | Film No.: 18726704
SIC: 2836 Biological Products, (No Diagnostic Substances)